Monday, August 10, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Coeur Mining Faces Market Scrutiny Following Major Acquisition

Rodolfo Hanigan by Rodolfo Hanigan
March 27, 2026
in Analysis, Commodities, Gold & Precious Metals, Mergers & Acquisitions
0
Coeur Mining Stock
0
SHARES
35
VIEWS
Share on FacebookShare on Twitter

The completion of Coeur Mining’s takeover of New Gold has been met with a wave of selling pressure. While the transaction dramatically reshapes the company’s production profile, a challenging macroeconomic backdrop for precious metals is clouding the strategic move.

A Challenging Sector Environment

The broader mining sector is facing significant headwinds. Since late February, the Morningstar US Metals and Mining Index has declined by 22.8 percent. Coeur Mining’s shares have underperformed this benchmark, losing approximately 34 percent over the same period. Rising energy costs and the prospect of sustained higher interest rates are creating pressure across the industry.

In recent trading, the equity fell more than nine percent to around 14 euros, dipping just below its 200-day moving average. The fundamental strength gained from the acquisition is tangible, but the countervailing force of these macro factors is equally real. The pace at which this balance may shift depends heavily on whether gold and silver prices can find stability in the coming weeks.

Analyst Adjustments Reflect Price Realities

In the wake of the deal’s formal closure on March 20, several investment banks have revised their financial models. The consensus message is clear: analysts maintain belief in the long-term investment thesis but are tempering near-term expectations to align with current commodity prices.

Should investors sell immediately? Or is it worth buying Coeur Mining?

Joe Reagor of Roth Capital maintained a “Buy” recommendation but reduced his price target from $29 to $24, citing weaker gold and silver prices. Cantor Fitzgerald upgraded the stock to “Buy” while simultaneously cutting its target from $24 to $20. BMO Capital Markets reinstated coverage with an “Outperform” rating and a $27 target, and ATB Cormark issued a “Buy” with a $25 price objective.

Transformed Production Scale

The integration of New Gold’s assets—specifically the New Afton and Rainy River mines—has led Coeur to significantly raise its medium-term output guidance. By 2026, the company anticipates its gold production will reach between 680,000 and 815,000 ounces, representing an increase of roughly 80 percent from prior forecasts. This is complemented by projected silver output of 18.7 to 21.9 million ounces and copper production of 50 to 65 million pounds.

This operational expansion is being supported by complementary financial strategies. The company has announced a share repurchase program authorizing up to $750 million and has instituted a dividend policy for the first time. Furthermore, negotiations are underway for a debt exchange relating to $400 million of New Gold bonds, aimed at optimizing the capital structure.

Ad

Coeur Mining Stock: Buy or Sell?! New Coeur Mining Analysis from August 9 delivers the answer:

The latest Coeur Mining figures speak for themselves: Urgent action needed for Coeur Mining investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 9.

Coeur Mining: Buy or sell? Read more here...

Tags: Coeur Mining
Rodolfo Hanigan

Rodolfo Hanigan

Related Posts

Applovin Stock
Analysis

AppLovin’s $40 Billion Wake-Up Call: When a 53% Growth Rate Isn’t Enough

August 8, 2026
Nel ASA Stock
Analysis

Nel ASA’s Two-Speed Story: Orders Accelerate While the P&L Keeps Bleeding

August 7, 2026
SANDISK Stock
Analysis

SanDisk’s $94 Billion Backlog Can’t Bridge the Gap Between Record Results and a Disappointed Market

August 7, 2026
Next Post
Eli Lilly Stock

Eli Lilly's Stock Hinges on Upcoming FDA Decision for Oral Weight-Loss Drug

Adobe Stock

Adobe's Strategic Acquisition Advances Amid Regulatory Scrutiny

Ocugen Stock

Analyst Confidence Surges for Ocugen Following Clinical Trial Data

Recommended

TG Therapeutics Announces Impressive Net Product Revenue Figures and Ambitious Goals for 2024

3 years ago
Chipotle Stock

Chipotle Shares Plummet Amidst Mounting Challenges

9 months ago
Unitedhealth Stock

UnitedHealth’s Resurgence: A Sustainable Recovery or Temporary Rally?

9 months ago
Finance_Capitalization

Analyzing Organogenesis Holdings Incs Q4 Earnings Performance

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Nvidia’s Latest Surge Is About More Than a Single Order

Plug Power’s Balancing Act: Property Sales Fund the Present While Australia’s Hydrogen Hub Points to the Future

Petrobras Delivers Record-Breaking Quarter, But Investors Keep Their Distance

Milan Fertility Clinic Suspended After Embryo Mix-Up Sparks Safety Reforms Across Europe

AppLovin’s $40 Billion Wake-Up Call: When a 53% Growth Rate Isn’t Enough

Atlassian’s €128.80 Spike: A Profitability Inflection Point Arrives Just as Growth Slows

Trending

Bajaj Mobility AG Stock
Automotive & E-Mobility

Bajaj Mobility’s Turnaround Bet: Insiders Buy, Traders Chase, and One Date Looms

by Kennethcix
August 9, 2026
0

The stock market has a way of pricing in good news before it's officially confirmed. For Bajaj...

D-Wave Quantum Stock

D-Wave Quantum: Inside the Insider Sales That Tell a Different Story Than the Headlines

August 9, 2026
Novo Nordisk Stock

Novo Nordisk’s Oral Push Marks a Sales Milestone as Trial Setbacks and Rival Pressure Keep the Spotlight on the Pipeline

August 8, 2026
Nvidia Stock

Nvidia’s Latest Surge Is About More Than a Single Order

August 8, 2026
Plug Power Stock

Plug Power’s Balancing Act: Property Sales Fund the Present While Australia’s Hydrogen Hub Points to the Future

August 8, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Bajaj Mobility’s Turnaround Bet: Insiders Buy, Traders Chase, and One Date Looms
  • D-Wave Quantum: Inside the Insider Sales That Tell a Different Story Than the Headlines
  • Novo Nordisk’s Oral Push Marks a Sales Milestone as Trial Setbacks and Rival Pressure Keep the Spotlight on the Pipeline

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com